A peptide signal, which may control nucleo-cytoplasmic protein tracking, was newly identi®ed in human immunode®ciency virus type I (HIV-1) Rev, a lentiviral post-transcriptional transactivator. The sequence, in the amino-terminal portion of HIV-1 Rev, maintains a Rev mutant with a dysfunctional nuclear/nucleolar targeting signal outside of the nucleus, although this Rev molecule itself is small enough to pass through the nuclear pores. Transition of this sequence to the N-terminus of human T-lymphocytic leukemia/lymphoma virus type I (HTLV-I) p21 x , which is usually located evenly distributed throughout the cell, resulted in capture of p21
Introduction
Mechanisms for active targeting protein molecules within cells have recently been uncovered. Targeting of proteins to a speci®c organelle generally requires speci®c signal sequences, which interact with other proteins. Such signal sequences have been identi®ed for the import of proteins into the endoplasmic reticulum, mitochondria, lysosomes, chloroplasts, nuclei, and nucleoli (Kornfeld et al., 1989; Kubota et al., 1989; Melchior and Gerace, 1995; Schmidt et al., 1995; Silver, 1991; Siomi et al., 1988; Siomi and Dreyfuss, 1995; Smeekens et al., 1990; Walter and Johnstone, 1994) . Among these intracellular protein tracking patterns, a particularly unique one is the tracking between the cytoplasm and the cell nucleus based on the nuclear pores in the nuclear membrane, through which import and export of proteins are carried out. The mechanisms for nuclear import have been investigated and it is now clear that nuclear import consists of two distinct steps, in which importins/ karyopherins and Ran/TC4 play central roles (Goldfarb, 1997; Melchior and Gerace, 1995) . For a variety of nuclear proteins, several members of importins ± importin a-b, transportin, Kap 123 ± have been identi®ed as the receptors for nuclear import (Rout et al., 1997) . For nuclear export, though the discovery of nuclear export signals (NES) occurred relatively recently , signi®cant advances are uncovering the mechanisms of nuclear export events. In early studies, several cellular proteins have been identi®ed as binding factors to the NES of the human immunode®ciency virus type I (HIV-1) Rev protein (Bogerd et al., 1995; Fritz et al., 1995; Kubota et al., 1995; Ruhl et al., 1993; Stutz et al., 1995) . Most recently, other factors have been identi®ed as the receptors for NES, and thus were renamed exportins (Fornerod et al., 1997; Kutay et al., 1997; Stade et al., 1997; Stutz et al., 1995; Ullman et al., 1997) . As such, comprehensive views of active protein tracking through the nuclear pore are gaining increased clarity.
Due to the nuclear pores, small proteins, with molecular weights of less than 60 kD, can relatively freely migrate into, or out, of the cell nucleus by nonspeci®c passive diusion. For these small molecules, even if they do possess either nuclear import or export signals, such nucleo-cytoplasmic targeting may be inecient due to the subtraction eect of passive diusion. Recently, a NES was identi®ed in the heatstable inhibitor of cAMP-dependent protein kinase (PKI), which is a quite small protein (8 kD) (Wen et al., 1995) . PKI is able to export the kinase catalytic subunit by forming a complex with it. Moreover, the NES of PKI can very eciently export 54 kD bacterial glutathione S-transferase (GST) out of the nucleus. However, PKI itself is not eectively excluded from the nucleus. It has been demonstrated that PKI itself is small enough to diuse back into the nucleus, rapidly enough to short circuit the competing active export (Wen et al., 1994) . Therefore, it is suggested that together with the passive diusion force, nuclear pores may sometimes interfere with the proper retention of molecules, in either the nucleus or cytoplasm. To overcome this constraint, mechanisms may have developed for certain small proteins to stay in the proper subcellular compartments. It is known that strict regulation of the nucleo-cytoplasmic tracking of some proteins, including mammalian nuclear factor-kappa B (NF-kB) (Henkel et al., 1992; Kerr et al., 1991) , yeast SW15 (Moll et al., 1991) , and SV40 T antigen (Jans et al., 1991) , are controlled by phosphorylation. Also for the proteins which shuttle between the nucleus and cytoplasm, such back-diusion through nuclear pores may cause undesirably rapid shuttling-back, which may short-circuit the functional pathway of such proteins, while consuming cellular co-factors for active transport. The smaller the proteins are, the more severe such in¯uences should be.
The Rev protein of HIV-1 is a post-transcriptional transactivator for structural and enzymatic viral gene expression. HIV-1 Rev enables unspliced and incompletely-spliced viral mRNAs to be eciently transported out of the nucleus, and translated on polysomes (Arrigo and Chen, 1991; D'Agostino et al., 1992; Fischer et al., 1994; . This process is carried out through the direct interaction between Rev and its structured RNA target, on such HIV-1 mRNAs, entitled the Rev responsive element (RRE) (Heaphy et al., 1991; Malim and Cullen, 1991; Zapp and Green, 1989) . A variety of independent studies have also demonstrated that Rev is constantly shuttling between the cytoplasm and the nucleus (Kalland et al., 1994; Meyer and Malim, 1994; Richard et al., 1994; Wol et al., 1995) , which is mediated by the nuclear/ nucleolar targeting signal (NLS/NOS) and the nuclear export signal (NES) of Rev itself (Fischer et al., 1995; Michael et al., 1995; Wen et al., 1995) .
Since the HIV-1 Rev protein is as small as 13 kD in molecular weight, theoretically, it could rapidly pass through nuclear pores by passive diusion. However, when Rev-expressing cells are treated with actinomycin D, which blocks active nuclear import of proteins by inhibiting cellular RNA transcription, Rev seems to be completely expelled from the nucleus (Kalland et al., 1994; Meyer and Malim, 1994; Richard et al., 1994; Wol et al., 1995) . This observation indicates that Rev may possess a moiety to maintain its presence in the cytoplasm, against a passive diusion force. Of note, there is a Rev mutant which harbors a deletion of seven amino acid residues in the NOS. This mutant, dRev, which is completely non-functional, is capable of blocking the replication of HIV-1 by inhibiting Rev function in a trans-dominant manner (Furuta et al., 1995; Kubota et al., 1992) . Interestingly, although dRev is even smaller than wildtype Rev, it remains in the cytoplasm without movement into the cell nucleus (Furuta et al., 1995; Kubota et al., 1992) . Similar observations have been reported for other Rev mutants, which have point mutations in the NOS domain (Berger et al., 1991) . Interestingly, such a mutant was shown to be de®cient in homo-oligomer formation, which may physically disable its diusion through the nuclear pores (Zapp et al., 1991) . These ®ndings imply that a signal, which is required for cytoplasmic retention of this small protein, should be located somewhere in Rev, other than the NOS domain. Of note, this prediction was further supported by a quite recent report that described the cytoplasmic retention of a composite Rev mutant with both NOS and NES dysfunctioned (Szilvay et al., 1997) . In this study, we report the identi®cation of such a signal sequence, a nuclear entry inhibitory signal (NIS) in the HIV-1 Rev protein. We further minimized this moiety to as short as 14 residues, veri®ed its function as a peptide signal in two diering backbones, and determined its role in HIV-1 Rev function itself.
Results
Deletion in the amino-terminal region impairs the cytoplasmic retention of an HIV-1 Rev mutant with a dysfunctional NOS It has been reported that the deletion of seven amino acids from residue numbers 38 to 44 causes complete exclusion of HIV-1 Rev protein from the nucleus (Furuta et al., 1995; Kubota et al., 1992; Szilvay et al., 1997) . To estimate the location of the region which is responsible for the cytoplasmic retention of this Rev mutant, two further mutant rev genes which contain extended deletions from the NOS towards the amino terminus were constructed, for expression in Cos-1 cells. The Rev mutant, which was entitled dRev46, harbors a deletion from residue numbers 23 ± 44, with four¯anking amino acid substitutions. The other mutant contains an extensive deletion from residues 17 ± 44 with two¯anking amino acid substitutions (dRev36; Figure 1a ). Ecient expression of these mutants was con®rmed by transient transfection experiments followed by immunoblotting (data not illustrated). When these Rev mutants were expressed in Cos-1 cells by transient transfection, remarkably, signals for these gene products were detected in both the cell nucleus as well as the cytoplasm, utilizing indirect immuno¯uorescence analyses. In sharp contrast to the cytoplasmic-retained mutant, dRev, no distinct nuclear exclusion was observed for dRev46 or dRev36 (Figure 1b ), although they still retain the NES sequences. The dierence in subcellular localization among the three mutants suggests a functional domain, near residue number 20, which enables the cytoplasmic retention of NOS-dysfunctional HIV-1 Rev mutants.
A 28 residue HIV-1 Rev fragment acts as a signal for the nuclear exclusion of an unrelated small protein at the amino terminus
There have been relatively few small proteins identi®ed which are diusely localized both to the cytoplasm and the nucleus in eukaryotic cells. One such protein is p21 x of human T-cell leukemia/lymphoma virus type I (HTLV-I), which is an accessory protein of this retrovirus, and is relatively well-characterized. As shown in Figure 2 and previous reports (Nosaka et al., 1989; Siomi et al., 1988) , p21
x is distributed evenly throughout the cell, which is an important phenotype for our objective. The primary structure of p21
x can be regarded as a naturally deleted form of the Rex protein, which is the functional equivalent of the Rev protein of HIV-1 (Nosaka et al., 1989; Seiki et al., 1988) . Translational initiation of p21
x occurs at an initiation codon which corresponds to the methionine codon at residue number 79 of Rex, using the same reading frame as Rex. The mRNA which is responsible for the expression of p21 x appears to be dierent from Rex, and the mRNA and p21
x protein itself have been detected in various HTLV-I-infected cell-lines and uncultured primary adult T-cell leukemic cells (Berneman et al., 1992; Furukawa et al., 1991; Orita et al., 1991) . Although these data may indicate some involvement for p21
x in the life-cycle of HTLV-I, its function is still unclear, save for certain reports which suggest possible roles for p21
x as a negative regulator HIV-1 Rev and nuclear entry S Kubota and RJ Pomerantz of viral gene expression (Furukawa et al., 1991; Kubota et al., 1996) . We transplanted an HIV-1 rev gene fragment, which was thought to involve the putative NIS, into the p21 x gene at its amino terminus. The fragment encodes residue numbers 10 ± 37 of the HIV-1 Rev protein (Figure 2a ). Expression and analyses of this chimeric protein (p21ATS) revealed that it was excluded from the nucleus, in sharp contrast to p21
x (Figure 2b ; quantitative data in Figure 9a ). To rule out the possibility that the nuclear exclusion eect, observed here, might be merely secondary to physical constraints in passing through the nuclear pores, due to the increased size of the protein, another control was prepared in addition to p21 x . The parental plasmid, pH2rexdL, expresses a Rex protein in which the methionine residue (number 79) is substituted with an isoleucine. This mutation does not aect the subcellular localization (Figure 2b ), or the function of this Rex protein, but eliminates the concomitant expression of p21
x from the mRNA, as described previously (Kubota et al., 1996) . Utilizing this construct, we have derived a plasmid which expresses a Rex mutant, CRex, lacking the 41 amino-terminal residues. As such, it can be regarded as a p21
x protein with a 38-residue extension towards the amino terminus, which is ten residues longer than the fused Rev fragment in p21ATS. Although CRex is larger than the p21 x -Rev chimera in molecular weight, it was still able to enter the nucleus, even without the NOS (Figure 2b ). At a steady state, it was distributed in the whole cell without any visible predominant site of localization. Therefore, the transplanted HIV-1 Rev fragment is shown to function as a signal for interfering with the passive entry of p21
x into the nucleus, when fused to this protein's amino terminus. Minimizing the nuclear entry inhibitory sequence to 15 amino acid residues by mutational analysis
To determine which portion of the HIV-1 Rev fragment is responsible for the cytoplasmic capture of the p21 x -Rev chimeric protein, three mutant chimeras were constructed. Two of these possess the Rev fragment with a carboxy-terminal deletion, the other has a Rev fragment with a truncated amino terminus ( Figure 3) . Both of the carboxy-terminal deletion mutants retained the ability to maintain p21
x out of the nucleus. Therefore, the carboxy-terminal prolinerich region, which is located immediately upstream of the NOS and is required for multimerization (Olsen et al., 1990) , is also dispensable for the nuclear exclusion activity. In contrast, deletion of the eight aminoterminal residues impaired the function of the signal sequence. As a consequence of these experiments, the NIS was demonstrated to be within the 15 amino acids of residues 10 ± 24 of the HIV-1 Rev protein (Figure 4 ).
The minimal NIS is also functional at the carboxy terminus in a mutant of a human ribosomal protein Despite no observed NES eect (i.e., no nuclear exclusion ± Figure 2 ), the NES sequence itself is still present in the primary structure of p21
x (Palmeri and Malim, 1996) , which may complicate further analysis of the NIS. To avoid such a complexity, we sought another backbone of unrelated protein. However, it is somewhat dicult to test the function of NIS in a backbone of small proteins which are native and functional in higher eukaryotic cells, as most of these proteins are actively targeted to speci®c cellular compartments ± probably their speci®c functional location within the cell. A technique to overcome this diculty is: As a ®rst step, destroy the active targeting signal of such a protein by mutagenesis, and obtain a mutant protein which displays even distribution within the cell. Then, it can be examined whether the construction or re-construction of the cytoplasmic retention of the mutant protein is accomplished by the addition of the HIV-1 Rev NIS.
In eukaryotic cells, a vast number of ribosomal proteins are synthesized in the cytoplasm, transported into the nucleus, complexed in the nucleoli, and exported out from the nucleus as parts of ribosomes. Not all the ribosomal proteins are genetically wellcharacterized. Among the ribosomal proteins, the cDNAs of which have been cloned and characterized, we utilized ribosomal protein S25 (RPS25) following the above mentioned strategy, as this protein is as small as HIV-1 Rev (Li et al., 1991) . The analysis of the nuclear/nucleolar targeting of RPS25 itself is ongoing (manuscript in preparation). Of note, the absence of a functional NES in RPS25 was con®rmed by immuno¯uorescence analyses, in the absence and presence of actinomycin D which revealed no eect on its dominant nuclear localization (data not illustrated), suggesting a dierent property of RPS25 as compared to HIV-1 Rev. While constructing and characterizing a variety of RPS25 mutants, we identi®ed a mutant showing an ambiguous intracellular distribution pattern, which was similar to HTLV-I p21
x . This mutant, RPS25dC, harbors eight unrelated amino acid residues which substitute for residues 32 ± 41 of RPS25 to disable the nuclear targeting, and a carboxy-terminal deletion of 34 residues (see Materials and methods for details). At the amino terminus, the protein was tagged with the FLAG epitope (IBI/ Kodak) for detection using a monoclonal antibody. Immuno¯uorescence analyses were carried out, utilizing this detection system. An oligonucleotide encoding 14 amino acid residues of the HIV-1 Rev NIS, with the omission of the ®rst glutamate residue, was fused to the 3' end of the RPS25dC cDNA, and its eect on the subcellular localization of the expressed protein was evaluated. The results of the immuno¯uorescence analyses of the transient expression experiments clearly demonstrated the acquired cytoplasmic retention of RPS25dC ( Figure  5 ). Thus, the Rev peptide sequence is also eective as a NIS at the carboxy terminus of a small mutant protein derived from a human ribosomal protein.
The NIS is required for HIV-1 Rev function
Although accumulated data of mutational analyses have indicated that the NIS region may be important for HIV-1 Rev function (Berger et al., 1991; , an alternative Rev mutant was created and characterized in order to more clearly evaluate the relationship between the function of NIS and Rev. In another section of this report, we have shown that a NIS mutant with a deleted amino terminus, which was entitled ATS-Nd2, was functionally defective in the backbone of HTLV-I p21 x . Retrospectively, we reintroduced the same short amino acid deletion into the HIV-1 Rev protein itself, and evaluated its function.
The construction of this mutant HIV-1 Rev was carried out by utilizing two available mutants, Rev M2 and Rev M3 . A composite cDNA of these mutants, Revd23, harbors the same short deletion as ATS-Nd2. This cDNA was built into the same backbone as the wild-type Rev, to be expressed in eukaryotic cells. Transient expression and immunoblotting analyses demonstrated equal levels of expression of this mutant, as compared to the wild-type, and the expected decrease of the apparent molecular weight in SDS ± PAGE (data not illustrated). Then, the function of Revd23 was evaluated by an integrated HIV-1 proviral assay (Figure 6a ). Each expression plasmid was transfected into HT-4 (V-dhfr) cells, which is a HeLa cell clone containing a Rev-defective HIV-1 provirus in its genome (Pomerantz et al., 1992) . Viral particles released by the rescue of exogenous functional Rev were measured by the level of the HIV-1 p24 CA protein in the culture supernatant. As shown in Figure  6b , the exogenous wild-type Rev eciently supported viral production from the Rev-defective provirus, whereas the mutant Revd23 did not. The level of HIV-1 p24 CA in the culture supernatant of HT-4 (Vdhfr) cells, which had been transfected with the Revd23 expression plasmid, was as low as the negative control. Since Revd23 is derived from Rev M2, it contains two amino acid residue substitutions, as well as the deletion of the NIS. However, this mutation has been demonstrated to retain Rev function, which was also reproducible in our laboratory , and data not illustrated). Additionally, the Rev function of these mutants was re-evaluated by an RRE-mediated chloramphenicol acetyl transferase (CAT) gene expression system. These experiments also completely supported the proviral rescue data (Figure 6c) . Thus, these studies further indicated that the NIS is one of the functional domains in the Rev protein during HIV-1 replication.
Conserved amino acid sequence motif in the NIS of HIV-1 Rev
If the NIS is an indispensable functional domain for HIV-1 Rev, conservation among Rev proteins from various HIV-1 isolates is expected. In Figure 7a , amino acid sequences from 11 diverse HIV-1 isolates were sorted and aligned. Some variation in the sequence itself can be found, particularly in the amino-terminal half. However, most interestingly, there is a strong bias for the selection of amino acid residues in each position. For example, although residue number 11 has ®ve variations, they are all charged or polar residues. The four variations in residue number 21 are all highly hydrophobic. Taken together, the NIS consists of a four times repeat of the triplet (charged/ polar ± hydrophobic ± hydrophobic), and the completely conserved ®nal two residues, tyrosine and glutamine. At residue number 15, this rule is not strictly observed, but the variation is limited to alanine and threonine. Of note, it has been experimentally proven that residues 8 ± 26 of HIV-1 Rev form an a-helix (Auer et al., 1994) , and a helical wheel diagram of the NIS HIV-1 Rev and nuclear entry S Kubota and RJ Pomerantz region, at a rotation angle of 1088, predicted an amphipathic helical structure (Figure 7b ). Taken together, these ®ndings suggest that the NIS of HIV-1 Rev is a conserved functional domain with a de®nite three-dimensional structure.
Point-mutational analyses suggests a functional requirement for the helical structure of the NIS Although the HIV-1 Rev NIS region has been shown to possess a consensus sequence and forms an a-helix, the relevance between the structure itself and the NIS function still remains obscure. To gain insights regarding this point, we created two point mutants of the NIS in the backbone of RPS25. One mutant, designated NIS-2, harbors two amino acid substitutions that reverse the positive charge of the side chains to negative, but still retains the JZZ motif, and would conserve the amphipathic helical structure itself. In contrast, the other mutant, NIS-3, does not change electrical polarity of the charged residues. Instead, two proline residues are used to replace the hydrophobic residues in the JZZ motif, and destabilize the amphipathic helical structure (Figure 8a ). Figures 8b and 9 , respectively, together with speci®c controls. The correlation between the predicted retention or loss of a-helical structure, and the function in those NIS mutants, strongly suggests the requirements of the helical structure for the HIV-1 Rev NIS function.
Discussion
In order to be stably maintained either in the nucleus or cytoplasm, small proteins have to possess some special means to allow them to resist passive diusion through the nuclear pores. This can be potentially obtained by the interaction of such small proteins with other molecule(s) in the cell, mediated by speci®c domains. In the Rev protein of HIV-1, we have identi®ed a short peptide signal sequence which promotes a steady state of small proteins outside of the nucleus, against passive diusion forces. Unlike a cytoplasmic retention signal of a large protein that is unable to enter the nucleus by passive diusion (Pines and Hunter, 1994) , it is likely that such a NIS should be particularly important for very small proteins to stay stably in the cytoplasm, against rapid diusion into the nucleus. As the size of a protein becomes larger, the diusion eciency becomes less than for a smaller protein, and it is able to stay more stably in the cytoplasm without any speci®c signal. The contrast, between the ecient nuclear exclusion of GST containing the NES of PKI, and the lack of detectable nuclear exclusion of PKI itself after microinjection into the nucleus, can be deduced from this simple theory for intracellular molecular movement, as discussed in a previous report (Wen et al., 1995) . Of note, also in our study, the eect of the NIS was observed more strongly in the smaller backbone (RPS25 mutant) than in the relatively larger (p21) (Figure 9 ), which is consistent with this theoretical implication. Here, an NIS seems to be necessary for the function of HIV-1 Rev. Rev is constantly shuttling between the cell nucleus and cytoplasm, under the control of a signal-mediated active import and export system, probably over the support of the NIS function (RPS25dC), respectively. These data are representative of at least two independent experiments, performed in duplicate HIV-1 Rev and nuclear entry S Kubota and RJ Pomerantz (Kalland et al., 1994; Meyer and Malim, 1994; Richard et al., 1994; Wol et al., 1995) . Of importance, Rev is a relatively small protein. Without the NIS, Rev may migrate back through the nuclear pore against the wellcontrolled nucleo-cytoplasmic shuttling to complete its role in each compartment. The concordance that the same deletions caused the loss of both NIS and Rev function indicates that the temporary cytoplasmic retention, enabled by the NIS, may be a part of the functional pathway of the HIV-1 Rev protein. This supplemental function of the NIS becomes clearer when our data and previous ®ndings are considered together. Evidently, the NIS function is discriminated from a NES by the behavior of NES-de®cient Rev mutants. Having intact NIS, these proteins remain in the nucleus, and have never been shown to migrate out of the nucleus, even after active nuclear import was inhibited by actinomycin D Wol et al., 1995) . Then, once the NOS was disabled in addition to the NES by mutation, such a Rev mutant remains outside of the nucleus (Szilvay et al., 1997) . These ®ndings strongly indicate that the NIS does not directly promote nuclear export of Rev, but helps them to stay in the assigned compartment. Therefore, the NIS may be the third identi®ed functional element to maintain nucleo-cytoplasmic shuttling of Rev in an eective manner, acting as a supplemental signal for the NES, and possible for the NOS. As well, the conserved motif of the NIS of Rev among HIV-1 isolates de®nes it as a potentially indispensable element. At present, the mechanism(s) of inhibition of nuclear entry by the NIS is unclear. Based on data which have been previously reported (Bogerd et al., 1995; Fritz et al., 1995; Kalland et al., 1994; Kubota et al., 1989; Meyer et al., 1994; Richard et al., 1994) , and demonstrated by this study, we can hypothesize a putative working mechanism(s) for the NIS. One possibility is that the NIS may bind to other cellular co-factor(s) which stay, or are bound, in the cytoplasm. Consequently, nuclear migration of NIS-containing proteins may be inhibited indirectly. As previously reported (Auer et al., 1994) , the NIS consists of an amphipathic helix, which is shown to be required for its function. Therefore, it is possible for the NIS to bind to the lipid-bilayer of biomembranes (Srinivas et al., 1992; Kaiser and Kezdy, 1987) , which include the nuclear membrane. If so, the NIS can be considered a light molecular anchor for small proteins to make temporary stops in various membranes, which cannot be removed by passive diusion, but can be overcome by an active transport force. It is also suspected that the NIS may form a complex, not with cellular factors, but with the NIS of another Rev molecule, to form a Rev multimer. There have been some reports indicating that several amino acid residues in the NIS region are required for in vitro and in vivo multimerization of the HIV-1 Rev protein (Malim et al., 1991; Zapp et al., 1991) . Even though a single Rev molecule is as small as 13 kD, it is likely that large multimers formed via the NIS domain may not be able to pass through the nuclear pores. However, the NIS function itself does not seem to be a mere consequence of multimerization for the following reasons. According to a number of mutational analyses and examinations of oligomer formation of HIV-1 Rev, domains other than the NIS are required for the multimerization of Rev (Madore et al., 1994; Malim et al., 1991; Olsen et al., 1990; Zapp et al., 1991) . As well, although certain mutations in the NIS disabled ecient multimer formation of Rev, the NIS region itself did not multimerize per se, which at most leaves a possibility that the NIS region may contribute indirectly to multimer formation. In other words, the NIS is necessary, but is not sucient for the multimer formation of HIV-1 Rev. In contrast, the isolated and transplanted NIS was suciently functional in two unrelated backbones, in the absence of any other segment of HIV-1 Rev, suggesting the independency of the NIS function from multimerization. In any case, searching for the binding target(s) of the Rev NIS may be one of the ®rst steps in further clarifying how the NIS functions. A series of experiments utilizing the yeast dihybrid system are on-going, to identify the cellular target factor(s) for the NIS motif, and to examine the formation of NIS-mediated protein multimers. At present in our hand, the NIS-NIS binding in yeast has been observed to be negative, as anticipated (data not illustrated).
It has been reported that residues 35 ± 50 of HIV-1 Rev can transport the b-galactosidase protein into the nucleus/nucleolus, further suggesting that the NIS motif is not directly involved in active nuclear translocation of Rev . Another study has shown that 17 R could be changed to an aspartic acid residue without impairing the nuclear localization of Rev, supporting the hypothesis herein . However, a study by (Hope et al., 1990 ) demonstrated interesting phenotypes when certain select mutations were created in the amino terminus of HIV-1 Rev. This study demonstrated that mutating three amino acids residues, including basic ones, within the NIS region, to mostly acidic residues, led to nuclear-exclusion. These ®ndings may be due to alterations in the secondary structure of Rev, masking the positively charged NOS with negative charges of introduced side chains. Such an intramolecular interaction may occur, since the NOS and the NIS are predicted to contact each other, owing to the helix ± loop ± helix structures which are connected by ā exible proline-rich chain (Auer et al., 1994; Tan et al., 1993) . The nuclear-exclusion of these mutants could also be due to the ablation of only one of four JZZ motifs in the NIS. Notably, our dysfunctional NIS mutants destroyed two full JZZ motifs within the NIS, or harbored a`helix breaker' in the middle.
From the amino terminus of HIV-1 Rev, the ®rst 30 residues contain the NIS domain which is also required for discrimination of RRE from non-speci®c RNA binding (Daly et al., 1995) . In the next 30 residues, the NOS domain is located, connected to the NIS by a proline-rich¯exible segment. To the NOS domain, further important roles are also assigned; direct binding to RRE and multimer formation (Heaphy et al., 1991; Kubota et al., 1989; Malim et al., , 1991 Olsen et al., 1990; Zapp et al., 1991) . The third 30 residues possess the NES, and the last 26 residues may be dispensable. Of note, further intricacies of the modularity of HIV-1 Rev may be demonstrated, especially in terms of multimerization (Madore et al., 1994; Szilvay et al., 1997) . Thus, analysis of the functional domain structure of HIV-1 Rev seems to allow further understanding of the complexities involved in HIV-1 replication. In terms of general cell biology, searching for and characterizing NIS in a variety of eukaryotic small proteins seems to be essential, to uncover the dynamic events in nucleocytoplasmic tracking of low molecular weight proteins. 
Materials and methods

Cell cultures
Cos-1 cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) in humidi®ed air containing 5% CO 2 at 378C. HT-4 (Vdhfr) is a HeLa cell-line which contains a rev-defective HIV-1 provirus, called V-dhfr, and expresses CD4 on its surface (Pomerantz et al., 1992) . The conditions for the maintenance of HT4 (V-dhfr) cells are the same as for Cos-1 cells.
Construction of plasmids for the HIV-1 Rev mutants
The plasmids, which express wild-type Rev and a mutant, dRev, have been previously described, and entitled pcREV and pH2drev , respectively. Three more deletion mutants were created by combining two fragments from dierent point mutants of pcREV, which possess common BglII sites at the locations of the mutations. The plasmid pcREVd46 is a combination of a 3.4 kb BglII ± XhoI fragment of pcREVM4 and a 0.47 kb BglII ± XhoI fragment of pcREVM6. Similarly, pcREVd36 was constructed using a 3.6 kb NcoI ± BglII fragment of pcREVM6 and a 0.47 kb NcoI ± BglII fragment of pcREVM3. The third mutant, pcREVd23, is composed of a 3.1 kb BglII ± EcoRI fragment of pcREVM2 and a 0.86 kb BglII ± EcoRI fragment of pcREVM3. All the original point mutants were described previously . Proper decreases of the electromobility of mutant Rev proteins were con®rmed by transient expressions in Cos-1 cells, followed by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS ± PAGE) and immunoblotting.
Construction of plasmids for the expression of p21 x -Rev chimeras
The polymerase chain reaction (PCR) technique was utilized for generating proper rev fragments, with¯anking restriction enzyme sites. A Rev expression vector, pH2rev , was used as a template. The following oligodeoxynucleotides were prepared as primers. Sense primers: 5'-TCGACGCGTTAGAAGAGCTCCTCAA-3' (for ATS, ATS-Nd1 and ATS-Nd3), 5'-CTTAAGCTTAATGGATCT-CATCAAGCTG-3' (for ATS-Nd2). Antisense primers: 5'-TCGACGCGTCAGCCTGTCTGGTAC-3' (for ATS, ATSNd2), 5'-TCGACGCGTCTGGATTTGGAGGTGG-3' (for ATS-Nd1), 5'-TCGACGCGTTTTGATAGAGCAGC-3' (for ATS-Nd3). PCR was performed with Pfu DNA polymerase (Stratagene) through 30 cycles of 45 s at 948C, 25 s at 538C, 20 s at 728C after heating the DNA solution for 5 min at 958C, followed by 1 min for completion of the elongation reaction. Isolated PCR products were digested either by MluI alone (for ATS, ATS-Nd1, and ATS-Nd3), or HindIII and MluI (for ATS-Nd2), then subcloned into the MluI site of pKCR21x (Kubota et al., 1996; Nosaka et al., 1989 ) (for ATS, ATS-Nd1, and ATS-Nd3), or substituting the 0.35 kb HindIII ± MluI fragment of pH2RexdL (for ATS-Nd2) (Kubota et al., 1996) . For the construction of the expression vector for CRex, the same strategy was applied using two primers to isolate a portion of the rex gene; Sense: 5'-CTTA-AGCTTAATGGACGCGTACAAGGCGAC-3'; Antisense: 5'-AACTCTAGAGCTCAGCCGA-3'. The PCR-ampli®ed rex gene fragment was placed in the MluI site of pKCR21x to generate pH2cRex, which was used as a control (CRex). All the chimeric cDNAs were sequenced, to con®rm the absence of undesirable mutations during PCR.
Cloning and construction of RPS25 cDNA expression plasmids
The detailed procedure for the molecular cloning and characterization of the RPS25 cDNA will be published elsewhere. Brie¯y, the major portion of the cDNA-encoding carboxy-terminal 84 amino acid residues was obtained from a cDNA clone in a bacteriophage lZAPII HeLa cell cDNA library (Stratagene). The amino terminus-encoding portion was constructed by direct ligation of four synthetic oligodeoxynucleotides. The amino acid substitution [ 32 KKKWSKGKVR 41 to EVVQRQSS] was inscribed herein. These cDNA fragments were assembled together between the HindIII and XhoI sites of pBluescript SK. The resultant plasmid was digested by SacI into three fragments. Relegation of the larger two fragments (3.0 kb and 0.46 kb) introduced an in-frame termination codon, immediately downstream of the codon for residue 91 of RPS25, which was entitled pBSRPSdC. The HindIII ± XhoI fragment of pBSRPSdC containing the mutant RPS25 cDNA was ligated together with oligonucleotides encoding the FLAG epitope tag (IBI/Kodak), into a 3.4 kb BglII ± XhoI fragment of pcREVM1 to provide transcription machinery and an ecient initiation codon, removing the rev cDNA. The resultant plasmid was termed pcFL-RPS25dC. Introduced mutations and deletions were con®rmed by sequencing. The RPS25dC protein, which was expressed in Cos-1 cells, displayed the expected electromobility on SDS ± PAGE and immunoblotting (not illustrated).
To construct the expression vector for the RPS25dC protein with the NIS of Rev, two oligodeoxynucleotides encoding the NIS and a subsequent termination codon were synthesized, and directly inserted between the internal SacI site and the XhoI site of pcFL-RPS25dC, replacing the carboxy terminus remnant from RPS25 cDNA.
The nucleotide sequences of the NIS oligonucleotides are: ATFP (sense) 5'-AGCTCTGAAGAGCTCCTTAAGGCAG-TCAGACTCA TCAAGCTTCTTTA TCAGGAT CCGTAA-C-3'. ATFM (anti-sense) 5'-TCGAGTTACGGATCCTGA-TAGA GAAGCTTGA TGAGTCT GACTGCCTT AAGGA-GCTCTTCAG-3'. Utilizing the A¯II and HindIII sites which were inscribed in these oligonucleotides, two point mutants of the NIS were generated by cassette mutagenesis, to be fused at the carboxy terminus of the RPS25dC protein. For the mutagenesis, a set of oligonucleotides, NIS-2P (sequence: 5'-TTAAGGCAGTAGATCTCATCG-3') and NIS-2M (sequence: 5'-AGCTCGATGAGATCTACTGCC-3'), were prepared and hybridized to each other forming a doublestranded DNA fragment, which substituted the 21 bp A¯II ± HindIII fragment of pcFLRPS24-NIS to become pcFLRPS25-NIS-2. Similar fragment replacement was performed with another set of oligonucleotides, NIS-3P (sequence: 5'-TTAAGCCTCCGCGGCTCATCA-3') and NIS-3M (sequence: 5'-AGCTTGATGAGCCGCGGAGGC-3'), to obtain pcFLRPS25-NIS-3. All the introduced mutations were con®rmed by DNA sequencing.
Antibodies
The rabbit antiserum, Rev1/20, was utilized for the detection of wild-type and mutant HIV-1 Rev at a dilution of 1 : 200 in immuno¯uorescence analysis (IFA) . For the detection of p21 x , p21
x -Rev chimeras, Rex and a Rex mutant, Anti-RexC, which had been raised against a carboxyterminal peptide of Rex, was employed for IFA at a dilution of 1 : 100 (Kubota et al., 1996) . A mouse monoclonal antibody, Anti-FLAGM2, raised against the amino-terminal tag peptide, was used for the IFA of RPS25dC with or without the NIS of Rev, at a dilution of 1 : 100. Fluorescein isothiocyanate (FITC)-conjugated anti-rabbit or anti-mouse IgG (Sigma) were employed as secondary antibodies at a dilution of 1 : 100.
DNA transfection and immuno¯uorescence analysis
Cos-1 cells (2.5610 4 cells per well) were seeded into Lab-Tek eight-well chamber slides (Nunc, Inc.), 24 h prior to transfection. Liposome-mediated DNA transfection was carried out, following a manufacturer's optimized protocol (LipofectAMINE: GIBCO BRL). For a single transfection, 200 ng of each plasmid was used. Cells were ®xed 48 h after transfection in 3.5% formaldehyde in Dulbecco's phosphatebuered saline (PBS), and permeabilized with 0.1% Nonidet P40 in PBS, as described previously (Kubota et al., 1991) . Incubation in primary and secondary antibodies was performed for 1 h at 378C, followed by extensive washes with PBS. After the secondary series of washes, cells were placed in a mounting medium (Omni¯uor: ViroStat) and analysed with an epi¯uorescence microscope (Olympus). Quantitative analyses were performed by classifying more than 50 IFA-positive cells viewed under the microscope for each experiment.
HIV-1 integrated proviral rescue assay
HT-4 (V-dhfr) cells (4610 5 cells per well), which contain a rev-defective HIV-1 provirus (Pomerantz et al., 1992) , were seeded into a six-well tissue culture plate, 20 h before transfection. One microgram of each expression plasmid was transfected, following the manufacturer's optimized protocol for HeLa cells with the same reagents as for immuno¯uorescence analysis (GIBCO BRL). Tissue culture supernatants of each transfectant were harvested 72 h posttransfection. The levels of released HIV-1 p24 capsid (CA) antigen in the culture supernatants were measured by a highly sensitive enzyme-linked immunosorbent assay (ELISA) system (Dupont/NEN).
HIV-1 Rev functional assay by a RRE-mediated CAT gene expression system
The chloramphenicol acetyl transferase (CAT) gene reporter plasmid system has been previously described . Cos-1 cells (2610 5 cells per well) were prepared in a six-well tissue culture plate, 20 h prior to transfection. An established DEAE-dextran method was employed for DNA transfection (Cullen, 1987) . Each transfection mixture contained 400 ng of pBennCATRRE, 100 ng of pH2Ftat and 500 ng of each Rev expression plasmid. Forty-eight hours after transfection, cells were harvested and CAT activity in cell lysates were elucidated, as previously described (Gorman et al., 1982) , using 2.5 mg of total protein in each cell lysate. Quanti®cation of the signals on thin-layer chromatography (TLC) plates were performed utilizing a phosphorimager (Molecular Dynamics).
